D
DATANEERRESEARCH INTELLIGENCE WORKSPACE
Research intelligence engine for teams that do not want to drown in search results

Stay ahead of research trends without drowning in search results

Dataneer monitors key topics across scientific sources and turns raw search results into concise weekly or daily briefings. You spend time on decisions and strategy, not on manual searching.

PubMed
Crossref
Patents
EPO
More to come

Dataneer is currently in a private alpha phase. Access is by invitation only.

EXAMPLE BRIEFINGMonday preview
Topic
Cardiovascular risk and GLP1 agonists
Sources
PubMed, Crossref, EPO
Frequency
Weekly
  • Three new phase two trials indicate improvement in cardiovascular endpoints for patients with high BMI.
  • One patent family filed in Europe on oral delivery with reduced side effects.
  • No major safety signal detected against last week baseline.

Dataneer uses configured queries and topics to build a concise weekly or daily overview that can be shared with decision makers or plugged into internal tools.

How Dataneer works

Three simple steps from search chaos to a calm research signal.

From configure topics to receive briefings

You define topics, Dataneer monitors scientific and patent sources, removes noise and sends a briefing that highlights what changed since the previous slice.

01

Configure topics

Define therapeutic areas, mechanisms of action and key terms. Combine clinical, scientific and patent queries in one workspace.

02

Dataneer monitors sources

Continuously pulls new content from PubMed, Crossref and patent databases, deduplicates results and filters out noise.

03

Receive briefings

You receive concise summaries and links in a format that can be shared with leadership, portfolio teams or embedded into internal systems.

Use cases

Different teams, one shared need to stay in front of new signals.

For pharma research teams, academic institutions and IP or patent teams.

Pharma R and D

Therapeutic area horizon scanning

Keep track of new trials, mechanisms of action and competition signals in one place instead of repeating the same manual searches week after week.

Academic teams

Literature and funding awareness

Help labs and departments see what is being published, where funding is moving and which collaborations might be relevant for the next period.

IP and patent teams

Emerging filings and technical trends

Surface new patent families and technical directions in your focus domains. Understand who is moving first and how portfolios are shifting.

FAQ

A few questions that often come up when teams look at Dataneer for the first time.

Are you really in a private alpha phase?
Yes. Dataneer is currently available only to a small set of pilot teams. This lets us refine the product based on real use before opening it more broadly.
What does private alpha mean for my team?
Access by invitation, closer onboarding and support, and the understanding that parts of the product can still change quickly based on feedback.
How does Dataneer handle data and security?
We focus on monitoring public scientific and patent sources. If you connect internal systems, access is limited to what you explicitly configure. As we move towards a broader release we will publish a structured security and privacy overview.
Which sources does Dataneer monitor?
Initial pilots use sources such as PubMed, Crossref and European patent data including EPO. The source set can be extended based on team needs.
Who is Dataneer for?
For teams that regularly work with scientific papers and patents and need a clear signal from them. Typical users are pharma research, academic groups and IP or portfolio teams.
How often will my team receive briefings?
Most pilots start with weekly briefings. For fast moving topics it is possible to configure a more frequent cadence.